上海优宁维生物科技股份有限公司代理商

19

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0
  • 0
  • 2
  • 2
代理商

上海优宁维生物科技股份有限公司

入驻年限:19

  • 联系人:

    上海总部

  • 所在地区:

    上海 浦东新区

  • 业务范围:

    试剂

  • 经营模式:

    代理商

在线沟通

公司新闻/正文

BioXcell特色抗体之:Immunology Research

346 人阅读发布时间:2023-01-28 10:49

新闻图片1新闻图片2新闻图片3

 

Antigen Reactivity Application Clone Catalog Number Isotype Control
2c TCR mouse IF, FC 1B2 BE0069 BE0083
4-1BB (CD137) mouse in vivo activation of 4-1BB LOB12.3 BP0169 BP0089
4-1BB (CD137) mouse in vivo and in vitro 4-1BB stimulation 3H3 BP0239 BP0089
4-1BB (CD137) mouse in vitro 4-1BB blockade, FC 17B5 BE0296 BE0087
4-1BBL (CD137L) mouse in vivo 4-1BBL blockade TKS-1 BE0110 BE0089
B220 mouse in vivo B cell depletion, in vitro B cell negative selection RA3.3A1/6.1 BE0067 BE0094
B7-1 (CD80) mouse in vivo B7-1 blockade, Affinity chromatography 1G10 BE0134 BE0089
BTLA (CD272) mouse in vivo BTLA stimulation, in vivo BTLA blockade 6A6 BE0132 BE0091
BTLA (CD272) mouse in vivo and in vitro stimulation of BTLA, FC PK18.6 BE0153 BE0088
BTLA (CD272) mouse in vivo BTLA blockade, in vitro T cell stimulation/activation, FC PJ196 BE0196 BE0083
BTLA (CD272) mouse in vivo BTLA+ B cell and CD4 T cell depletion, FC 6F7 BE0304 BE0083
c-Kit (CD117) mouse FC, IF, IHC 2B8 BE0280 BE0090
c-Kit (CD117) mouse in vivo mast cell depletion, in vivo c-Kit+ cell depletion, in vitro c-Kit neutralization, IP, FC ACK2 BE0293 BE0090
CCL2 (MCP-1) mouse/human/rat in vivo CCL2 neutralization, IHC-F 2H5 BE0185 BE0091
CCR3 (CD193) mouse in vivo eosinophil depletion 6S2-19-4 BE0316 BE0090
CD1a human in vitro CD1a blockade, FC OKT-6 BE0211 BE0083
CD1d (CD1.1) mouse in vivo CD1d neutralization 19G11 BE0000 BE0088
CD1d (CD1.1) mouse in vivo CD1d blockade, iNKT cell neutralization, FC 20H2 (HB323) BE0179 BE0088
CD3 human in vivo T cell depletion in humanized mice, in vitro T cell stimulation/activation, ex vivo T cell inhibition for xenographs, FC OKT-3 BE0001-2 BE0085
CD3 mouse in vitro T cell stimulation/activation 17A2 BE0002 BE0090
CD3 human in vivo T cell depletion in humanized mice, ex vivo T cell inhibition for xenographs, FC UCHT1 (Leu-4) (T3) BE0231 BE0083
CD3e mouse in vivo T cell depletion, in vitro T cell stimulation/activation, IF, FC 145-2C11 BP0001-1 BP0091
CD3e mouse in vitro T cell negative selection, in vitro T cell stimulation/activation, IF KT3 BE0261 BE0089
CD3e F(ab')2 fragment mouse in vivo T cell depletion 145-2C11 f(ab')2 Fragments BE0001-1FAB BE0091-FAB
CD4 mouse in vivo CD4+ T cell depletion, FC GK1.5 BP0003-1 BP0090
CD4 human in vitro T cell stimulation/activation, in vivo CD4+ T cell depletion in humanized mice, FC, IP OKT-4 BE0003-2 BE0086
CD4 mouse in vivo blockade of CD4+ T-cell responses, WB YTS177 BE0003-3 BE0089
CD4 mouse in vivo CD4+ T cell depletion YTS 191 BE0119 BE0090
CD4 human in vitro CD4 blockade, in vitro blocking of CD4+ T cell activation, IF, IHC-F, FC RPA-T4 BE0288 BE0083
CD4 rat in vivo CD4+ T cell depletion, FC OX-38 BE0308 BE0085
CD8 (Lyt 2.1) mouse in vivo CD8+ T cell depletion, FC 116-13.1 (HB129) BE0118 BE0085
CD8a mouse in vivo CD8+ T cell depletion, IF, FC 53-6.7 BP0004-1 BP0089
CD8a human in vivo CD8+ T cell depletion in humanized mice OKT-8 BE0004-2 BE0085
CD8a mouse in vivo CD8+ T cell depletion 2.43 BP0061 BP0090
CD8a mouse in vivo CD8+ T cell depletion YTS 169.4 BE0117 BP0090
CD8P (Lyt 3.2) mouse in vivo CD8+ T cell depletion, in vitro CD8 blockade, IF 53-5.8 BE0223 BE0088
CD11b mouse/human in vivo CD11b neutralization, ILC2 cell purification, FC M1/70 BE0007 BE0090
CD16/CD32 mouse in vitro and in vivo Fc receptor blocking 2.4G2 BE0307 BE0090
CD19 mouse in vivo B cell depletion, in vivo CD19 neutralization, in vitro B cell negative selection, FC 1D3 BE0150 BE0089
CD19 human Functional assays, Chimeric antigen receptor construction, FC, IF 4G7 BE0281 BE0083
CD20 mouse in vivo B cell depletion, WB MB20-11 BP0356 BP0366
CD22 mouse in vivo B cell depletion in combination with anti-CD19 (clone 1D3) and anti-rat K Light Chain (clone MAR 18.5), FC, IP Cy34.1 BE0011 BE0083
CD24 mouse in vivo administration, IHC-F, IHC-P, IF, FC M1/69 BE0360 BE0090
CD25 (IL-2Ra) mouse in vivo regulatory T cell depletion, FC PC-61.5.3 BP0012 BP0088
CD25 (IL-2Ra) human IP, IF 7G7B6 BE0014 BE0085
CD27 mouse in vivo CD27 stimulation, in vitro CD27 stimulation, IP, FC RM27-3E5 BE0348 BE0089
CD28 mouse in vitro T cell stimulation/activation, in vivo CD28 blockade 37.51 BE0015-1 BE0087
CD28 mouse in vitro T cell stimulation/activation PV-1 BE0015-5 BE0091
CD28 mouse in vivo and in vitro T cell stimulation/activation D665 BE0328 BE0083
CD32 (FcyRIIA) human in vivo FcyRIIA blockade in humanized mice, in vitro FcyRIIA blockade, ELISA, FC IV.3 BE0224 BE0086
CD38 mouse in vivo and in vitro CD38 stimulation, in vitro B cell activation, IF NIMR5 BE0317 BE0089
CD40 mouse in vivo CD40 activation, in vitro B cell stimulation/activation FGK4.5/FGK45 BE0016-2 BP0016-2


新闻图片4

新闻图片5

 

Antigen Reactivity Application Clone Catalog Number Isotype Control
CD40 human in vitro B cell stimulation, in vitro macrophage stimulation, Functional assays, FC G28.5 BE0189 BE0083
CD40L (CD154) mouse in vivo and in vitro blocking of CD40/CD40L signaling MR-1 BE0017-1 BP0091
CD40L (CD154) human/monkey in vivo and in vitro blocking of CD40/CD40L signaling, IP, FC 5C8 BE0292 BE0085
CD45RB mouse in vivo anti-CD45RB-mediated tolerance induction, in vivo pre-mNK cell depletion MB23G2 (HB220) BE0019 BE0089
CD45.2 mouse FC, IHC-F, in vitro CD45.2 blockade, in vivo CD45.2 blockade 104.2 BE0300 BE0085
CD47 human in vivo CD47 neutralization in human tumor xenograft models or humanized mice, in vitro CD47 neutralization, FC B6H12 BE0019-1 BE0083
CD47 human/mouse/rat in vivo and in vitro CD47 blockade, IF MIAP410 BE0283 BP0083
CD47 (IAP) mouse in vivo CD47 blockade, in vitro CD47 blockade, IF MIAP301 BE0270 BE0089
CD48 mouse in vivo and in vitro CD48 blockade HM48-1 BE0147 BE0091
CD54 (ICAM-1) mouse in vivo ICAM-1 neutralization YN1/1.7.4 BE0020-1 BE0090
CD69 mouse in vivo down-regulation of CD69 expression, Functional assays CD69.2.2 BE0330 BE0083
CD70 mouse in vivo and in vitro CD70 blockade, FC FR70 BE0022 BE0090
CD71 (TfR1) mouse in vivo depletion of CD71+ cells R17 217.1.3/TIB-219 BP0175 BP0089
CD71 (TfR1) mouse in vivo depletion of CD71+ cells, IF, IHC-F, WB 8D3 BP0329 BP0089
CD71 (TfR1) rat/mouse Targeted drug delivery to the brain, IHC-F, FC OX-26 BE0331 BE0085
CD73 mouse in vivo CD73 blockade TY/23 BE0209 BE0089
CD80 (B7-1) mouse in vivo CD80 blockade, FC 16-10A1 BE0024 BE0091
CD86 (B7-2) mouse in vivo CD86 blockade, FC GL-1 BE0025 BE0089
CD96 mouse in vivo and in vitro CD96 blocking, FC 3.3 BE0337 BE0088
CD103 mouse in vivo CD103 neutralization, IF, FC M290 BE0026 BE0089
CD106 (VCAM-1) mouse in vivo VCAM-1 neutralization, IF M/K-2.7 BE0027 BE0088
CD122 (IL-2RP) mouse in vitro NK cell negative selection, IP, FC 5H4 BE0272 BE0089
CD122 (IL-2RP) mouse in vivo NK cell depletion, in vitro IL-2R blockade, Functional assays, FC TM-Beta 1 BE0298 BE0090
CD132 (common Y chain) mouse in vivo Yc blockade, Functional assays, IP, FC 3E+12 BE0271 BE0090
CD172a (SIRPa) mouse in vivo and in vitro SIRPa blocking, WB, IP, FC P84 BE0322 BE0088
CD200 (OX2) mouse in vivo and in vitro CD200 blockade, IHC-F, IF, FC OX-90 BE0299 BE0089
CD209b (SIGN-R1) mouse in vivo SIGN-R1 blockade, IHC-F, WB, FC 22D1 BE0220 BE0091
CD276 (B7-H3) mouse in vivo B7-H3 blockade, FC MJ18 BE0124 BE0088
CD314 (NKG2D) mouse in vivo and in vitro NKG2D blockade, FC CX5 BE0334 BE0088
CD317 (BST2, PDCA-1) mouse in vivo pDC depletion, IF, FC 927 BE0311 BE0090
CLEC9A (CD370) mouse in vivo Ag targeting to CLEC9A+ DCs, WB, ELISA, IP, IF, FC 7H11 BE0305 BE0088
CSF1 mouse in vitro CSF1 neutralization 5A1 BE0204 BE0088
CSF1R (CD115) mouse in vivo macrophage depletion, in vivo monocyte depletion, in vitro CSF-R1 neutralization, FC AFS98 BE0213 BP0089
CTLA-4 (CD152) mouse in vivo and in vitro CTLA-4 neutralization, FC UC10-4F10-11 BE0032 BP0091
CTLA-4 (CD152) mouse in vivo and in vitro CTLA-4 neutralization 9H10 BE0131 BP0087
CTLA-4 (CD152) mouse in vivo CTLA-4 neutralization 9D9 BE0164 BP0086
CTLA-4 (CD152) human in vitro CTLA-4 neutralization, FC BN13 BE0190 BE0085
CXCL9 (MIG) mouse IF MIG-2F5.5 BE0309 BE0091
CXCR3 (CD183) mouse in vivo CXCR3 neutralization, FC CXCR3-173 BE0249 BE0091
Delta-like protein 4 (DLL4) mouse in vivo DLL4 neutralization HMD4-2 BE0127 BE0091
DR5 (CD262) mouse in vivo induction TRAIL-mediated apoptosis, in vitro induction TRAIL-mediated apoptosis MD5-1 BE0161 BE0091
F4/80 mouse in vivo Monocyte/Macrophage depletion, Functional assays, IHC-P, IHC-F, FC CI:A3-1 BE0206 BE0090
FasL (CD178) mouse in vivo and in vitro FasL blockade, Functional assay, IHC-P, FC MFL3 BE0319 BE0091
FGL-1 mouse in vivo and in vitro FGL-1 blockade, FC, IHC-P 177R4 BE0332 BE0083
Galectin-9 mouse in vivo and in vitro Galectin-9 blockade RG9-1 BE0218 BE0090
GITR mouse in vivo GITR stimulation DTA-1 BE0063 BP0090
GM-CSF mouse in vivo and in vitro GM-CSF neutralization, FC MP1-22E9 BE0259 BE0089
ICOS mouse in vivo blocking of ICOS/ICOSL signaling, FC 7E.17G9 BE0059 BE0090
ICOSL (CD275) mouse in vivo ICOSL neutralization HK5.3 BE0028 BE0089
IFNAR-1 mouse in vivo and in vitro IFNAR-1 blockade MAR1-5A3 BE0241 BP0083
IFNy mouse in vivo and in vitro IFNY neutralization R4-6A2 BE0054 BE0088
IFNy mouse in vivo and in vitro IFNY neutralization, ELISPOT, FC XMG1.2 BE0055 BP0088


新闻图片6新闻图片7

 

Antigen Reactivity Application Clone Catalog Number Isotype Control
ifny human in vitro IFNy neutralization B133.5 BE0235 BE0083
ifny human FC B27 BE0245 BE0083
ifny mouse in vivo and in vitro IFNy neutralization H22 BE0312 BE0091
IFNyR (CD119) mouse in vivo IFNyR neutralization GR-20 BE0029 BE0089
IFNyRq (CD119) mouse WB, IP, FC 200 BE0287 BE0091
IL-1 R (CD121a) mouse in vitro IL-1 R blockade JAMA-147 BE0256 BE0091
IL-1a mouse in vivo IL-1a neutralization ALF-161 BE0243 BE0091
IL-1P mouse/rat in vivo and in vitro IL-1p neutralization, ELISA B122 BE0246 BE0091
IL-2 mouse in vivo and in vitro IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2), ELISPOT, FC JES6-5H4 BE0042 BE0090
IL-2 mouse in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2) JES6-1A12 BE0043 BE0089
IL-2 mouse in vivo IL-2 neutralization, in vivo IL-2 receptor stimulation (as a complex with IL-2) S4B6-1 BE0043-1 BE0089
IL-3 mouse in vivo and in vitro IL-3 neutralization, in vivo IL-3 receptor stimulation (as a complex with IL-3), ELISA, FC MP2-8F8 BE0282 BE0088
IL-4 mouse in vitro and in vivo IL-4 neutralization, in vivo IL-4 receptor stimulation (as a complex with IL-4), FC 11B11 BP0045 BP0088
IL-4 mouse ELISA, ELISPOT, FC BVD6-24G2 BE0199 BE0088
IL-4 human in vitro IL-4 neutralization, FC MP4-25D2 BE0240 BE0088
IL-5 mouse/human in vivo IL-5 neutralization, in vivo eosinophil depletion TRFK5 BE0198 BE0088
IL-6 mouse in vivo IL-6 neutralization, in vitro IL-6 neutralization MP5-20F3 BE0046 BE0088
IL-6R mouse in vivo blocking of IL-6/IL-6R signaling, in vitro blocking of IL-6R signaling 15A7 BE0047 BE0090
IL-7 mouse/human in vivo IL-7 neutralization, in vivo IL-7 receptor stimulation (as a complex with IL-7) M25 BE0048 BE0086
IL-7Ra (CD127) mouse in vivo blocking of IL-7Ra signaling, FC A7R34 BE0065 BE0089
IL-9 mouse in vivo IL-9 neutralization 9C1 BE0181 BE0085
IL-9 human FC, ELISA MH9A4 BE0327 BE0086
IL-10 mouse in vivo IL-10 neutralization, in vitro IL-10 neutralization JES5-2A5 BE0049 BE0088
IL-10R (CD210) mouse in vivo blocking of IL-10/IL-10R signaling, in vitro blocking of IL-10R signaling, FC 1B1.3A BP0050 BP0088
IL-12 mouse in vitro IL-12 neutralization R1-5D9 BE0052 BE0089
IL-12 p40 mouse in vivo IL-12p40 neutralization, p40 affinity chromatography, IP, ELISA, FC, WB C17.8 BP0051 BP0089
IL-12 p70 human Functional assays, ELISA, FC 20C2 BE0234 BE0088
IL-12 p75 mouse in vivo IL-12p75 neutralization, ELISA R2-9A5 BE0233 BE0090
IL-15 mouse in vivo and in vitro IL-15 neutralization AIO.3 BE0315 BE0089
IL-17A mouse in vivo IL-17A neutralization 17F3 BP0173 BP0083
IL-17F mouse in vivo IL-17F neutralization MM17F8F5.1A9 BE0303 BE0083
IL-18 mouse in vivo IL-18 neutralization YIGIF74-1G7 BE0237 BE0089
IL-21R mouse in vivo IL-21R blockade 4A9 BE0258 BE0089
IL-23 (p19) mouse in vivo IL-2C1843p19 neutralization; WB G23-8 BE0313 BE0088
IL-27 p28 mouse in vivo and in vitro IL-27 p28 neutralization, FC MM27.7B1 BE0326 BE0085
Jagged2 mouse in vivo Jagged 2 neutralization HMJ2-1 BE0125 BE0091
Kappa Immunoglobulin Light Chain rat in vivo administration, FC MAR 18.5 BE0122 BE0085
Kappa Immunoglobulin Light Chain mouse IF 187.1 (HB58) BE0176 BE0088
KLRG-1 mouse/human FC 2F1 BE0201 BE0087
LAG-3 mouse in vivo and in vitro LAG-3 neutralization, FC C9B7W BP0174 BP0088
Ly6C mouse in vivo macrophage depletion (in combination with clodronate liposomes), FC Monts 1 BE0203 BE0089
Ly6G mouse in vivo neutrophil depletion, in vivo MDSC depletion, IF, IHC-P, IHC-F, FC 1A8 BP0075-1 BP0089
Ly6G/Ly6c (Gr-1) mouse in vivo neutrophil depletion, IHC-P, IHC-F, IF, FC NIMP-R14 BE0320 BE0090
Ly6G/Ly6C (Gr-1) mouse in vivo depletion of Gr-1+ myeloid cells, FC, IHC-P, IHC-F RB6-8C5 BP0075 BP0090
MDR-1 (CD243) human/monkey in vivo MDR-1 blocking/depletion in xenogeneic murine tumor models, in vitro MDR-1 blocking, IHC-P UIC2 BE0340 BE0085
MHC Class I (H-2) mouse ex vivo blocking of MHC I-dependent interactions, IF, FC M1/42.3.9.8 BE0077 BE0089
MHC Class I (H-2Kb) mouse in vivo administration, FC AF6-88.5.5.3 BE0121 BE0085
MHC Class I (H-2Kb) mouse in vivo MHC II blockade, Functional assays, Purification of MHC peptide complexes, FC Y-3 BE0172 BE0086
MHC Class I (H-2Kb) bound to SIINFEKL mouse in vivo blocking of Kb -SIINFEKL, Functional assays, FC 25-D1.16 BE0207 BE0083
MHC Class I (H-2Kd, H-2Dd) mouse in vivo activation of APCs 34-1-2S BE0180 BE0085
MHC Class I (H-2Kd) mouse in vivo administration, Purification of MHC peptide complexes, FC SF1.1.10 (HB159) BE0104 BE0085
MHC Class I (H-2Kk, H-2Dk) mouse in vivo administration, FC 15-3-1S (HB13) BE0158 BE0085


新闻图片8新闻图片9

 


详情请咨询 BioXcell 中国授权代理-优宁维生物

上海优宁维生物科技股份有限公司

试剂 | 耗材 | 仪器 | 软件 | 定制 | 实验服务 | 供应链

免费热线:4008-168-068

咨询邮箱:info@univ-bio.com

订购商城:www.univ-bio.com

微信公众平台:优宁维抗体专家,欢迎关注!

小优博士(小程序):5大课堂, 让你的科研不再难!


上一篇

酶联/荧光免疫斑点分析技术常见问题解答

下一篇

BioXcell特色抗体之:肿瘤细胞粘附和迁移

更多资讯

我的询价